Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia. 1973

I Kline, and M Gang, and R J Woodman, and R L Cysyk, and J M Venditti

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D001745 Urinary Bladder Diseases Pathological processes of the URINARY BLADDER. Bladder Diseases,Bladder Disease,Urinary Bladder Disease
D003498 Cyclic P-Oxides Heterocyclic P-Oxides,Cyclic P Oxides,Heterocyclic P Oxides,Oxides, Cyclic P,P Oxides, Cyclic,P-Oxides, Cyclic,P-Oxides, Heterocyclic
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug

Related Publications

I Kline, and M Gang, and R J Woodman, and R L Cysyk, and J M Venditti
January 1974, Cancer chemotherapy reports,
I Kline, and M Gang, and R J Woodman, and R L Cysyk, and J M Venditti
April 1976, Cancer treatment reports,
I Kline, and M Gang, and R J Woodman, and R L Cysyk, and J M Venditti
July 2001, The Laryngoscope,
I Kline, and M Gang, and R J Woodman, and R L Cysyk, and J M Venditti
January 1974, Cancer chemotherapy reports,
I Kline, and M Gang, and R J Woodman, and R L Cysyk, and J M Venditti
October 1972, Cancer chemotherapy reports,
I Kline, and M Gang, and R J Woodman, and R L Cysyk, and J M Venditti
January 1975, Cancer chemotherapy reports,
I Kline, and M Gang, and R J Woodman, and R L Cysyk, and J M Venditti
August 2013, International journal of molecular medicine,
I Kline, and M Gang, and R J Woodman, and R L Cysyk, and J M Venditti
March 1980, Cancer research,
I Kline, and M Gang, and R J Woodman, and R L Cysyk, and J M Venditti
October 2009, Acta oto-laryngologica,
Copied contents to your clipboard!